Annual Retained Earnings
-$21.80 M
-$760.50 M-102.95%
31 December 2023
Summary:
Emergent BioSolutions annual retained earnings is currently -$21.80 million, with the most recent change of -$760.50 million (-102.95%) on 31 December 2023. During the last 3 years, it has fallen by -$748.70 million (-103.00%). EBS annual retained earnings is now -102.29% below its all-time high of $950.30 million, reached on 31 December 2021.EBS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$181.10 M
+$114.80 M+38.80%
30 September 2024
Summary:
Emergent BioSolutions quarterly retained earnings is currently -$181.10 million, with the most recent change of +$114.80 million (+38.80%) on 30 September 2024. Over the past year, it has dropped by -$208.80 million (-753.79%). EBS quarterly retained earnings is now -118.98% below its all-time high of $954.10 million, reached on 31 March 2022.EBS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -103.0% | -753.8% |
3 y3 years | -103.0% | -123.6% |
5 y5 years | -105.9% | -148.3% |
EBS Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -102.3% | at low | -119.0% | +38.8% |
5 y | 5 years | -102.3% | at low | -119.0% | +38.8% |
alltime | all time | -102.3% | at low | -119.0% | +38.8% |
Emergent BioSolutions Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$181.10 M(-38.8%) |
June 2024 | - | -$295.90 M(+2211.7%) |
Mar 2024 | - | -$12.80 M(-41.3%) |
Dec 2023 | -$21.80 M(-103.0%) | -$21.80 M(-178.7%) |
Sept 2023 | - | $27.70 M(-90.4%) |
June 2023 | - | $289.70 M(-47.4%) |
Mar 2023 | - | $551.00 M(-25.4%) |
Dec 2022 | $738.70 M(-22.3%) | $738.70 M(-10.1%) |
Sept 2022 | - | $822.00 M(-8.4%) |
June 2022 | - | $897.70 M(-5.9%) |
Mar 2022 | - | $954.10 M(+0.4%) |
Dec 2021 | $950.30 M(+30.7%) | $950.30 M(+23.7%) |
Sept 2021 | - | $768.50 M(-4.1%) |
June 2021 | - | $801.20 M(+0.6%) |
Mar 2021 | - | $796.60 M(+9.6%) |
Dec 2020 | $726.90 M(+72.3%) | $726.90 M(+34.2%) |
Sept 2020 | - | $541.50 M(+7.9%) |
June 2020 | - | $502.00 M(+22.6%) |
Mar 2020 | - | $409.30 M(-3.0%) |
Dec 2019 | $421.80 M(+14.8%) | $421.80 M(+12.5%) |
Sept 2019 | - | $374.90 M(+13.0%) |
June 2019 | - | $331.70 M(-2.8%) |
Mar 2019 | - | $341.30 M(-7.1%) |
Dec 2018 | $367.30 M(+9.0%) | $367.30 M(-0.9%) |
Sept 2018 | - | $370.73 M(+6.0%) |
June 2018 | - | $349.78 M(+16.7%) |
Mar 2018 | - | $299.64 M(-11.1%) |
Dec 2017 | $337.10 M(+32.5%) | $337.10 M(+11.2%) |
Sept 2017 | - | $303.13 M(+12.4%) |
June 2017 | - | $269.58 M(+1.7%) |
Mar 2017 | - | $264.96 M(+4.1%) |
Dec 2016 | $254.48 M(-27.5%) | $254.48 M(+18.5%) |
Sept 2016 | - | $214.69 M(-37.6%) |
June 2016 | - | $344.18 M(-3.1%) |
Mar 2016 | - | $355.13 M(+1.1%) |
Dec 2015 | $351.14 M | $351.14 M(+10.5%) |
Sept 2015 | - | $317.79 M(+13.2%) |
Date | Annual | Quarterly |
---|---|---|
June 2015 | - | $280.85 M(+5.3%) |
Mar 2015 | - | $266.75 M(-7.5%) |
Dec 2014 | $288.27 M(+14.6%) | $288.27 M(+11.7%) |
Sept 2014 | - | $258.15 M(+9.2%) |
June 2014 | - | $236.32 M(+2.2%) |
Mar 2014 | - | $231.29 M(-8.0%) |
Dec 2013 | $251.53 M(+14.1%) | $251.53 M(+6.4%) |
Sept 2013 | - | $236.31 M(+6.1%) |
June 2013 | - | $222.81 M(+4.9%) |
Mar 2013 | - | $212.33 M(-3.7%) |
Dec 2012 | $220.39 M(+11.9%) | $220.39 M(+7.9%) |
Sept 2012 | - | $204.29 M(+3.3%) |
June 2012 | - | $197.67 M(+4.0%) |
Mar 2012 | - | $190.04 M(-3.5%) |
Dec 2011 | $196.87 M(+13.2%) | $196.87 M(+17.0%) |
Sept 2011 | - | $168.21 M(+0.9%) |
June 2011 | - | $166.66 M(+9.3%) |
Mar 2011 | - | $152.45 M(-12.3%) |
Dec 2010 | $173.85 M(+42.3%) | $173.85 M(+17.8%) |
Sept 2010 | - | $147.60 M(+9.8%) |
June 2010 | - | $134.48 M(+7.9%) |
Mar 2010 | - | $124.67 M(+2.1%) |
Dec 2009 | $122.15 M(+34.2%) | $122.15 M(+3.6%) |
Sept 2009 | - | $117.92 M(+0.8%) |
June 2009 | - | $116.97 M(+14.5%) |
Mar 2009 | - | $102.13 M(+12.2%) |
Dec 2008 | $91.01 M(+29.4%) | $91.01 M(+1.6%) |
Sept 2008 | - | $89.55 M(+13.1%) |
June 2008 | - | $79.17 M(+2.3%) |
Mar 2008 | - | $77.35 M(+10.0%) |
Dec 2007 | $70.33 M(+46.5%) | $70.33 M(+65.1%) |
Sept 2007 | - | $42.59 M(+7.2%) |
June 2007 | - | $39.74 M(-11.1%) |
Mar 2007 | - | $44.70 M(-6.9%) |
Dec 2006 | $48.00 M(+89.0%) | $48.00 M(+119.8%) |
Sept 2006 | - | $21.84 M(-14.0%) |
Dec 2005 | $25.40 M(+65.8%) | $25.40 M(+65.8%) |
Dec 2004 | $15.32 M | $15.32 M |
FAQ
- What is Emergent BioSolutions annual retained earnings?
- What is the all time high annual retained earnings for Emergent BioSolutions?
- What is Emergent BioSolutions annual retained earnings year-on-year change?
- What is Emergent BioSolutions quarterly retained earnings?
- What is the all time high quarterly retained earnings for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly retained earnings year-on-year change?
What is Emergent BioSolutions annual retained earnings?
The current annual retained earnings of EBS is -$21.80 M
What is the all time high annual retained earnings for Emergent BioSolutions?
Emergent BioSolutions all-time high annual retained earnings is $950.30 M
What is Emergent BioSolutions annual retained earnings year-on-year change?
Over the past year, EBS annual retained earnings has changed by -$760.50 M (-102.95%)
What is Emergent BioSolutions quarterly retained earnings?
The current quarterly retained earnings of EBS is -$181.10 M
What is the all time high quarterly retained earnings for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly retained earnings is $954.10 M
What is Emergent BioSolutions quarterly retained earnings year-on-year change?
Over the past year, EBS quarterly retained earnings has changed by -$208.80 M (-753.79%)